EGRX receives CRL for Ryanodex in heatstroke: https://finance.yahoo.com/news/eagle-pharmaceuticals-receives-complete-response-163000438.html …the FDA has requested that the Company conduct an additional clinical trial for RYANODEX for Exertional Heat Stroke. The NDA was based on one small study conducted in Saudi Arabia. The stock is currently halted. p.s. The FDA is not approving everything, as some people have recently asserted.